TMX Newsfile

IN THE PRESS

Skye Bioscience Stockholders Vote in Favor of Arrangement Agreement with Emerald Health Therapeutics, Inc.

October 3, 2022

·

5 min read

Drug Development

Cardiol Therapeutics Announces Pre-Clinical Study Results Demonstrating CardiolRx(TM) Inhibits and also Promotes Reversal of Mechanisms Leading to Cardiac Fibrosis

October 3, 2022

·

6 min read

BioHarvest Sciences Inc. Reports Record Sales Results in Q3 2022 with Strong Momentum Building on All Fronts

October 3, 2022

·

7 min read

Naturevan Expands Distribution to Asia

October 3, 2022

·

5 min read

Genetown

AIM Biotech Launches organiX, a New System to Model Human Disease by Combining Organoids, Perfusable Vasculature and Immune-Competence

October 3, 2022

·

1 min read

Policy

Defence Therapeutics Is Granted Patents in Japan and Israel Expanding Its Novel ADC Platform Technology in the Fast Growing Antibody-Drug Conjugates Market

September 29, 2022

·

4 min read

NervGen Pharma Announces Results of Annual General Meeting of Shareholders.

September 29, 2022

·

5 min read

Drug Development

Nova Mentis Psilocybin Microdose Capsule Formulation to be Submitted in Health Canada Phase 2A Clinical Trial Application

September 29, 2022

·

4 min read

Cardiol Therapeutics Announces Poster Presentation at The Annual Scientific Meeting of the Heart Failure Society of America

September 28, 2022

·

4 min read

Business

Satellos Bioscience Inc. Announces the Appointment of Philip D. Lambert, Ph.D, as Chief Technology Officer

September 28, 2022

·

6 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750